Syros Pharmaceuticals Inc Revenue per Employee (SYRS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Syros Pharmaceuticals Inc   (NASDAQ: SYRS)
 

Syros Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Syros Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 8,234, but the productivity of Syros Pharmaceuticals Inc 's employees remained above the company average.
Within the Healthcare sector Syros Pharmaceuticals Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Syros Pharmaceuticals Inc has 47 employees.


What is Sales per Employee Ratio?







SYRS Revenue per Employee (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Revenue Change - - - - -3.32 %
Sales per Employee (TTM) $ 8,234 88,277 148,553 211,404 187,128
SYRS's Total Ranking # # # # 3536 # 3299
Seq. Revenue Change - - - -89.71 % 32.79 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 537,064 $ 259,297 $ 42,170
(Jun 30 2022)   (Dec 31 2019)



Financial Statements
Syros Pharmaceuticals Inc 's Revenue MRQ $ 0 Millions Visit SYRS's Income Statement
Syros Pharmaceuticals Inc 's Revenues TTM $ 0 Millions Visit SYRS's aggregate revenue growth
What are SYRS's Sales? Visit SYRS's Sales by Segment




Other Ratios
Syros Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SYRS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SYRS's Competitors
Revenue per Employee for SYRS's Suppliers
Revenue per Employee for SYRS's Customers

You may also want to know
SYRS's Sales Growth Rates SYRS's Pe Price to earnings ratio SYRS's Receivables Turnover Ratio SYRS's Stock Quote
SYRS's Net Income Growth Rates SYRS's Ps Price to Sales ratio SYRS's Sales per Employee SYRS's Asset Turnover Ratio
SYRS's Net Margin SYRS's Pb Price to Book ratio SYRS's Financial Strength Ratios SYRS's Dividend Payout Ratio
Date modified: 2026-08-29T17:37:42+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2024Number of Employees Sep 30 2024
Singular Genomics Systems Inc   14,031.58 $ 2.666  Million 190 
Traws Pharma inc   13,294.12 $ 0.226  Million 17 
Insight Molecular Diagnostics Inc   12,224.14 $ 0.709  Million 58 
Orgenesis Inc   11,675.32 $ 0.899  Million 77 
Pluri Inc   11,074.07 $ 0.598  Million 54 
Immunitybio inc   10,610.71 $ 7.332  Million 691 
Skinvisible Inc   10,000.00 $ 0.020  Million
Praxis Precision Medicines Inc   9,553.57 $ 1.605  Million 168 
Aim Immunotech Inc   9,047.62 $ 0.190  Million 21 
Aditxt Inc   8,159.85 $ 0.212  Million 26 
Upstream Bio Inc   8,093.33 $ 0.607  Million 75 
Serina Therapeutics Inc   7,875.00 $ 0.126  Million 16 
Foxo Technologies Inc   6,984.38 $ 1.341  Million 192 
Scpharmaceuticals Inc   6,920.69 $ 30.278  Million 4,375 
Clene Inc   5,329.11 $ 0.421  Million 79 
Cytokinetics Incorporated  4,783.06 $ 3.219  Million 673 
Aclarion Inc   4,480.82 $ 0.049  Million 11 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.